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Abstract
The melanocortin-2-receptor (MC2R)/MC2R accessory protein (MRAP) complex is critical to the production of
glucocorticoids from the adrenal cortex. Inactivating mutations in either MC2R or MRAP result in the clinical condition
familial glucocorticoid deficiency. The localisation of MC2R together with MRAP within the adrenal gland has not
previously been reported. Furthermore, MRAP2, a paralogue of MRAP, has been shown in vitro to have a similar function
to MRAP, facilitating MC2R trafficking and responsiveness to ACTH. Despite similar MC2R accessory functions, in vivo,
patients with inactivating mutations of MRAP fail to be rescued by a functioning MRAP2 gene, suggesting differences in
adrenal expression, localisation and/or function between the two MRAPs. In this study on the rat adrenal gland, we
demonstrate that while MRAP and MC2R are highly expressed in the zona fasciculata, MRAP2 is expressed throughout
the adrenal cortex in low quantities. In the developing adrenal gland, both MRAP and MRAP2 are equally well expressed.
The MC2R/MRAP2 complex requires much higher concentrations of ACTH to activate compared with the MC2R/MRAP
complex. Interestingly, expression of MC2R and MRAP in the undifferentiated zone would support the notion that ACTH
may play an important role in adrenal cell differentiation and maintenance.
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Introduction
Glucocorticoids are produced by the zona fasciculata
(ZF) of the adrenal cortex in response to ACTH
stimulation of the melanocortin-2-receptor (MC2R),
also known as the ACTH receptor. Ligand binding and
activation of this G protein-coupled receptor princi-
pally results in stimulation of adenylyl cyclase, which
catalyses the conversion of ATP to cAMP. Subsequent
activation of protein kinase A leads to phosphorylation
of cAMP response element protein, which in turn
activates the transcription of genes involved in ster-
oidogenesis (Lefkowitz et al. 1970, Lehoux et al. 1998).
It has emerged over recent years that the MC2R is
dependent on the co-expression of an accessory
protein, the MC2R accessory protein (MRAP; Metherell
et al. 2005). The MC2R only responds to ACTH in
heterologous cells when co-expressed with MRAP
(Metherell et al. 2005, Roy et al. 2007, Sebag & Hinkle
2007), and knockdown of MRAP in mouse adrenal Y1
cells (Cooray et al. 2008) and inactivating mutations in
patients with familial glucocorticoid deficiency type 2
(FGD type 2; OMIM #607398) (Metherell et al. 2005)
lead to loss of ACTH responsiveness. It is also clear that
MRAP mRNA is expressed in the adrenal gland
(Metherell et al. 2005). It is generally assumed that
the glucocorticoid-producing fasciculata cell expresses
both MC2R and MRAP, although this has not been
formally established. Furthermore, MRAP has a single
paralogue in the mammalian genome – MRAP2.
MRAP and MRAP2 share a 39% amino acid identity in
the N-terminus and transmembrane domain (Chan
et al. 2009). The MRAP2 gene is expressed in the
brain and the adrenal gland. In vitro MRAP2 appears
to have a qualitatively similar ability to MRAP,
enabling MC2R trafficking from the endoplasmic
reticulum to the cell surface and the formation of a
functional ACTH receptor (Chan et al. 2009). However,
studies with mouse or zebrafish MRAP2 did not show
this effect when a lower concentration of ACTH was
used (Sebag & Hinkle 2009, Agulleiro et al. 2010). Since
the presence of MRAP2 in the adrenal gland does not
protect patients with MRAP mutations from developing
glucocorticoid deficiency, the question arises as to
whether MRAP and MRAP2 are expressed at different
levels, in different cell types or whether they
differ functionally to lower doses of ACTH. In this
study, we analysed the quantitative expression, ana-
tomical localisation and functional properties of these
two MRAPs.
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Materials and methods
Plasmid and probes
Vectors used in the cAMP reporter assays, MRAP-flag
and MRAP2-flag were cloned, as previously described
(Chan et al. 2009). HA-MC2R was purchased from
the Missouri S&T cDNA Resource Center (University of
Missouri at Rolla, Rolla, MO, USA). Templates for creating
riboprobes for in situ hybridisation (ISH) were produced
by inserting full-length Mrap (forward primer
5 0-CTGTCCCGTTCACCAGCTAT-3 0, reverse primer
5 0-TAACCATTGGTCAATGCCAG-3 0), Mrap2 (forward
primer 50-CTGTGAAGGGCTCTCTGACC-30, reverse pri-
mer 50-GAACACATCCTCAGGAAGGC-30), or Mc2r (for-
ward primer 50-ATCTGCAGTTTGGCCATTTC-30, reverse
primer 50-ATGCCATTGACCTGGAAGAG-30) cDNA pro-
duced from rat adrenal RNA into pGEMT-Easy vector
(Promega). All constructs were confirmed by sequencing.
Nonradioactive-ISH and immunohistochemistry
Adrenal glands from adult Wistar male rats were
snap frozen, or fixed in 4% paraformaldehyde and
embedded in paraffin. Wistar rat embryos (embryonic
day 17.5) were collected in ice-cold PBS (Sigma), fixed in
4% paraformaldehyde, cryoprotected in 30% sucrose
and embedded in OTC compound (Fisher Scientific,
Loughborough, UK). Digoxigenin (DIG)-labelled
sense and antisense cRNA riboprobe production
and nonradioactive-ISH (NR-ISH), or combined
NR-ISH/immunohistochemistry (IHC), were per-
formed as reported by Guasti et al. (2010). Briefly, after
NR-ISH staining, sections were blocked with 10% normal
goat serum and incubated overnight at room tempera-
ture with anti-CYP11B1 mouse monoclonal antibody (a
gift of Dr C Gomez-Sanchez, University of Mississippi
Medical Center, Jackson, MS, USA) diluted 1:20 in PBS-
Triton X-100 0.1%. The sections were then washed and
incubated for 2 h with goat anti-rabbit Alexa Fluor 488
secondary (Invitrogen) diluted 1:1000 in PBS and, after
further washes, reacted with 40,6-diamidino-2-phenylin-
dole (DAPI; Sigma) for 1 min. Images were captured
using a Leica DC200 camera (Leica, Solms, Germany)
equipped with a DCViewer software (Leica), imported
into Photoshop (Adobe Systems), and bright field ISH
images were converted into black and white, inverted
and pseudo-coloured to red before merging them with
the immunofluorescence images in RGB mode.
Real-time quantitative RT-PCR
cDNA was synthesised from rat total adrenal RNA
(extracted from the adrenal glands of two adult male
Wistar rats) by reverse transcription using M-MLV Reverse
Transcriptase (Promega), following the manufacturer’s
guidelines. Gene expression levels were analysed by SYBR
Green assays, using KAPA SYBR Fast Universal qPCR kit
(Anachem, Luton, UK) and a Stratagene thermocycler.
Thermal profile used: 1! 95 8C for 3 min, 40! (95 8C for
3 s, 55 8C for 20 s and 72 8C for 1 s), 1! (95 8C for 1 min,
55 8C for 30 s and 95 8C for 30 s). Primers used for rat
cDNA were Mrap (forward, 5 0-ATTCTGCTCTACAT-
GTCCTG-30, reverse, 50-TACTTCCTGGCTCATCTG-30)
and Mrap2 (forward, 50-CAGAGGCTGACTTCTAACAG-
3 0, reverse, 5 0-CAGAATCCAATCACGATG-3 0). Gene
expression of the housekeeping gene Gapdh was used
for normalisation (forward, 50-TGCACCACCAACTGCT-
TAG-30, reverse, 50-GGATGCAGGGATGATGTTC-30) for
rat cDNA. Experiments were performed in duplicate
and repeated three times. Data were analysed using
MxPro software (Stratagene, Stockport, UK). TheCt value
of the unknown wasquantified absolutelyby interpolating
the quantity from a standard curve, whose quantities were
pre-determined spectrophotometrically at OD 260 nm
(NanoDrop ND-1000 spectrophotometer; Wilmington,
DE, USA).
Cell culture, transfection and cAMP reporter assay
Human embryonic kidney (HEK293) cells were grown in
DMEM (Sigma) containing 10% foetal bovine serum
(Sigma) and penicillin/streptomycin (Invitrogen). Cells
were grown to around 70–80% confluency in six-well
plates and transfected with HA-MC2R, plus either MRAP-
flag, MRAP2-flag, MRAP-flag and MRAP2-flag or pcDNA
3.1(C) empty vector, along with aGSU-846 luciferase and
pRL-CMV Renilla luciferase plasmid constructs, using
Lipofectamine 2000 (Invitrogen), following the manufac-
turer’s instructions. Twenty-four to forty-eight hours after
transfection, cells were stimulated for 6 h with ACTH1–39
at concentrations of 10K4 to 10K11 M. Whole cell lysates
were collected and assayed using the Dual-Luciferase
Reporter Assay System (Promega). Luciferase activity was
measured using a multiplate reader (LUMIstar Omega;
BMG Labtech, Aylesbury, UK) and normalised to the
pRL-CMV Renilla luciferase activity.
Statistical analysis
The data represent meanGS.E.M. of at least three indepen-
dent experiments performed in duplicate. Prism software
(La Jolla, CA, USA) was used to evaluate EC50 values.
Statistical analysis was performed using Student’s t-test.
Results
Mrap, Mrap2 and Mc2r localisation in the adult
and foetal rat adrenal gland
ISH was performed to visualise the localisation of
Mrap, Mrap2 and Mc2r mRNA expression within the
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adrenal gland (Fig. 1). Mrap and Mrap2 were
readily detectable specifically in the adrenal gland
during development (Fig. 1A–F). Mrap and Mrap2
NR-ISH was performed in combination with CYP11B1
IHC, which demonstrated that cortical, but not
medullary cells, expressed Mc2r accessory proteins
(Fig. 1G–G 00).
In the adult adrenal gland, Mrap and Mc2r were
expressed throughout the cortex (Fig. 1H–K), although
their expression was weaker in the zona glomerulosa
(ZG) compared with the ZF. In the ZF, a gradient was
observed with higher levels of expression seen at the
periphery decreasing towards the cortico-medullary
boundary. When combined Mc2r NR-ISH/CYP11B1
IHC was performed, the inner layer of cells within the
undifferentiated zone (ZU), also known as the zona
intermedia, which was negative for CYP11B1, was
strongly positive for Mc2r expression (Fig. 1L–L 00).
Combined Mrap NR-ISH/CYP11B1 IHC revealed the
same pattern of expression (data not shown). In
contrast, Mrap2 was detected at low levels throughout
all zones of the adrenal cortex (Fig. 1M).
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Figure 1 In situ hybridisation showing localisation of Mrap, Mrap2 and Mc2r in foetal and adult Wistar rat
adrenal glands. (A–G) Foetal Wistar rat adrenal glands (embryonic age 17.5 days); (H–N) adult male Wistar
rat adrenal glands. (A and B) Low-magnification images of foetal rat adrenal glands incubated with Mrap
antisense and sense (S) riboprobes.Mrap is present throughout the foetal rat adrenal gland. The sense probe
resulted in no specific staining. (C and D) 10! magnified images of foetal rat adrenal glands. No Mrap
staining in the adrenal capsule (C) or subcapsular zone (indicated by T). (E and F) Foetal rat adrenal glands
incubated withMrap2 antisense and sense (S) riboprobes.Mrap2 is present throughout the foetal rat adrenal
gland. The sense probe resulted in no specific staining. (G) Combined Mrap ISH and CYP11B1
immunohistochemistry. Nuclei are stained with DAPI. Cells positive for Mrap also express CYP11B1,
suggesting these cells are capable of glucocorticoid synthesis and are destined to localise to the zona
fasciculata postnatally. (H–K)Mc2r andMrap are present in the zona fasciculata (ZF), with relative sparing of
the capsule, zona glomerulosa (ZG) and medulla (M). Expression was strongest at the periphery, with a
gradient reduction towards the medulla. The sense probes resulted in no specific staining (h, j). (L) Combined
Mc2r ISH and CYP11B1 immunohistochemistry. Mc2r is expressed in the ZF, in cells co-expressing
CYP11B1. Mc2r is also expressed highly in the undifferentiated zone, in cells which lack CYP11B1
expression. (M and N) Mrap2 is expressed at low levels throughout the adult rat adrenal gland. The sense
probe resulted in no specific staining (N).
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Quantification of Mrap and Mrap2 in rat
adrenal gland
Quantitative PCR was performed on rat total adrenal
gland cDNA for Mrap and Mrap2 expression. Results
were expressed relative to Gapdh or copy numbers per
reaction. Mrap was expressed at significantly higher
levels compared with Mrap2 (18! greater than Mrap2
when expressed relative to Gapdh, P!0.0001, and
21! greater when expressed as copy number per
reaction, PZ0.0015; Fig. 2).
Functional MC2R differences between MRAP
and MRAP2
HEK293 cells, which lack endogenous melanocortin
receptors, were transfected with MC2R and either
MRAP, MRAP2 or both. Stimulation with ACTH
generated a dose-dependent increase in cAMP pro-
duction, as assessed by the luciferase activity produced
from the cAMP-responsive aGSU-846 luciferase
reporter construct. Cells transfected with MC2R and
MRAP2 were able to produce cAMP; however they
required significantly higher concentrations of
ACTH to achieve this (EC50 1!10K9 for MRAP and
9.3!10K7 for MRAP2; P!0.0001). Cells expressing
both MRAP and MRAP2 did not exhibit a reduction or
augmentation of the MRAP/MC2R cAMP response to
ACTH stimulation (Fig. 3).
Discussion
The importance of MRAP in MC2R function is
exemplified by the clinical condition of FGD, in
which disabling mutations of either gene results in
life-threatening isolated glucocorticoid deficiency
(Metherell et al. 2005). Although the expression of
MRAP has been demonstrated in the adrenal gland by
RT-PCR, little is known about the localisation of MRAP
mRNA within the different zones of the adrenal gland
(Metherell et al. 2005). In addition, the presence of
MRAP2 in the adrenal gland could indicate the
potential for redundancy (Chan et al. 2009), although
this is unlikely as patients with MRAP mutations are not
rescued by an intact MRAP2 gene.
Our ISH studies have shown that Mrap and Mc2r are
highly expressed in the rat adrenal ZF in cells
expressing CYP11B1 and thus being capable of
glucocorticoid synthesis. The level of expression
appears to be highest at the periphery, with a gradient
reduction towards the medulla. Interestingly, the high-
est level of Mrap and Mc2r expression is in the inner
part of ZU, directly adjacent to the ZF. The ZU lies
between the ZF and ZG in the adult rat adrenal and has
been postulated to contain stem cells that contribute to
steroidogenic cell maintenance (Wright & Voncina
1977, Mitani et al. 2003). Expression of Mrap and Mc2r
in the ZU in relatively undifferentiated, CYP11B1-
negative cells is interesting and suggests that ACTH
may have a role in adrenal cell differentiation and
maintenance. The concept that ACTH plays an
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Figure 2 Quantification of Mrap and Mrap2 in rat adrenal gland.
Expression of Mrap and Mrap2 in total adult Wistar rat adrenal
glands (A) normalised to Gapdh showing a 18-fold reduction in
Mrap2 relative toMrap (P!0.0001), nZ3. (B) Expressed as copy
numbers per reaction showing a 21-fold reduction in Mrap2
relative to Mrap (PZ0.0015), nZ3. (C) Agarose gel image
demonstrating the expression of Mrap and Mrap2 in rat adrenal
gland by RT-PCR.
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important role on adrenal growth and adrenal zonal
maintenance has been proposed for some time
(reviewed in Karpac et al. (2007) and Chan et al.
(2011)). Hypophysectomised animal models have
adrenocortical atrophy (Robinson et al. 1983) and
similarly atrophied adrenal glands were noted in
POMC-knockout mice (Coll et al. 2004, Karpac et al.
2005). The administration of ACTH alone appeared to
restore adrenal weight, morphology and function to
normal in these models (Robinson et al. 1983, Coll et al.
2004). The adrenal histology of FGD would support the
suggestion that MC2R and/or MRAP may be important
for adrenal zonal development as the glands from
deceased patients demonstrate disorganisation of
glomerulosa cells with almost complete absence of
fasciculata and reticularis cells (Clark & Weber 1998).
In comparison to the high expression levels seen with
Mrap and Mc2r, ISH studies for Mrap2 showed very low
levels of expression in adult rat adrenal but high
expression in the developing adrenal gland. Real-time
RT-PCR quantification of Mrap and Mrap2 expression
in the adult rat adrenal gland demonstrated that
Mrap expression is significantly greater than Mrap2
expression, supporting the low expression levels
detected by ISH.
We previously showed that MRAP2 was able to rescue
the expression and function of the MC2R in non-
adrenal cells (Chan et al. 2009). Later studies, however,
suggested that although MRAP2 was capable of assisting
MC2R to the cell surface, the receptor was unresponsive
to ACTH (Sebag & Hinkle 2009, Agulleiro et al. 2010).
Here, we demonstrate that MRAP2 does indeed enable
functioning of the MC2R in response to ACTH
stimulation in vitro; however, much higher concen-
trations of ACTH are required to generate the same
amount of cAMP in the presence of MRAP2 compared
with MRAP. The 1000-fold difference in EC50 provides
an explanation and hence agreement for the different
results obtained by other groups who utilised different
ACTH doses for stimulation (Chan et al. 2009, Sebag &
Hinkle 2009, Agulleiro et al. 2010). It is likely that
even in FGD type 2, where ACTH concentrations are
often O1000 pg/ml (Clark & Weber 1998), this is still
inadequate to stimulate MC2R function. This suggests
that although MRAP2 can enable MC2R function, this is
not its role in vivo.
Studies have shown that MRAP2 can heterodimerise
with MRAP in vitro (Chan et al. 2009) and such
heterodimers adopt an antiparallel conformation
(Chan et al. 2009, Sebag & Hinkle 2010). Western
blotting of tissues has revealed band sizes of which are
suggestive of homodimers rather than heterodimers
(Cooray et al. 2008, Chan et al. 2009). Nevertheless,
experiments on Y1 and CHO cells suggest that MRAP2
has an inhibitory role and competes with MRAP to bind
the MC2R, reducing cAMP production in response to
ACTH stimulation (Sebag & Hinkle 2010) in vitro. In
this study, we did not show any reduction in cAMP
generation of the MRAP/MC2R complex with
the addition of MRAP2. Likewise, another study on
zebrafish MRAP2 did not report an inhibitory effect,
but found that MRAP2 had additive effects on the
MRAP/MC2R cAMP response to ACTH (Agulleiro et al.
2010). This may, however, represent the different
cell lines used in the studies and hence different
levels of expression achieved (Chan et al. 2009, Agulleiro
et al. 2010, Sebag & Hinkle 2010). While the
hypothesis of a dominant-negative action of MRAP2 is
an attractive one, it is difficult to envisage such a
mechanism in view of the low levels of MRAP2
expression in adrenal tissue, the diffuse zonal local-
isation in the adrenal gland and the amount of MRAP2
expression that may be required to significantly shift the
EC50 for this to be relevant. Whether MRAP2 expression
in the foetal adrenal gland determines the tone of the
hypothalamic–pituitary–adrenal axis in adult life has yet
to be studied and can only be answered with the
generation of knockout mice.
In conclusion, we have demonstrated that Mc2r,
Mrap and CYP11B1 are co-expressed in fasciculata cells
in the rat adrenal gland, consistent with their role in
ACTH stimulation of steroidogenesis. Furthermore,
Mrap and Mc2r are expressed in some cells of the rat
adrenal ZU, suggesting that ACTH may be important in
adrenal cell differentiation and maintenance. The role
of MRAP2 in the adrenal gland is unclear. Although
MRAP2 is capable of facilitating MC2R function in
response to ACTH stimulation, the concentration of
ACTH required is much higher than that likely to be
generated in vivo. However, the apparent high
expression of MRAP2 in the developing adrenal
gland may suggest a role in early development.
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Figure 3 MC2R response to ACTH in the presence of MRAP or
MRAP2 or both. HEK293 cells were transiently transfected with
HA-MC2R, aGSU846-luc, pRL-CMV Renilla luciferase and either
MRAP-Flag, MRAP2-Flag, MRAP-Flag and MRAP2-Flag or
empty vector together with and stimulated with ACTH for 6 h.
Dose–response curves demonstrating a right shift in the case of
MRAP2. EC50 1!10K9 for MRAP and 9.3!10K7 for MRAP2;
P!0.0001. EV, empty vector.
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Availability of global or tissue-specific Mrap2-knockout
mice would certainly help clarify the role of this
protein during development and in adult homeostasis.
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